Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. - Wikidata - wikimedia - TriplyDB

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients.

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients.

http://www.wikidata.org/entity/Q35605761

about

Mammary gland stem cells and their application in breast cancer RCP is a human breast cancer-promoting gene with Ras-activating function Ferroportin and iron regulation in breast cancer progression and prognosis Clustering gene expression data with a penalized graph-based metric.Comparative study of joint analysis of microarray gene expression data in survival prediction and risk assessment of breast cancer patients.Identification of cancer genes using a statistical framework for multiexperiment analysis of nondiscretized array CGH data.The removal of multiplicative, systematic bias allows integration of breast cancer gene expression datasets - improving meta-analysis and prediction of prognosis.Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer A compact VEGF signature associated with distant metastases and poor outcomes.Can survival prediction be improved by merging gene expression data sets?Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics.Expression signatures of TP53 mutations in serous ovarian cancers.Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models Network pharmacology-based and clinically relevant prediction of the active ingredients and potential targets of Chinese herbs in metastatic breast cancer patients.Computational approach for deriving cancer progression roadmaps from static sample data.Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile.A fuzzy gene expression-based computational approach improves breast cancer prognostication Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers Basal keratin expression in breast cancer by quantification of mRNA and by immunohistochemistry.Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.Tracing the tumor lineage.How many etiological subtypes of breast cancer: two, three, four, or more?The embryonic transcription cofactor LBH is a direct target of the Wnt signaling pathway in epithelial development and in aggressive basal subtype breast cancers Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53-mutant breast cancers.Relation between radiographic BI-RADS scores and triple negativity in patients with ductal carcinomas.A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer.Cancer progression modeling using static sample data Prevalence of molecular subtypes and prognosis of invasive breast cancer in north-east of Morocco: retrospective study.TWIST1 associates with NF-κB subunit RELA via carboxyl-terminal WR domain to promote cell autonomous invasion through IL8 production New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence Clinicopathlogic and immunohistochemical characteristics of triple negative invasive lobular carcinoma.Effects of age on the detection and management of breast cancer.Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer.Household income is associated with the p53 mutation frequency in human breast tumors Epidemiology of basal-like breast cancer.Enhanced anticancer effect of the combination of cisplatin and TRAIL in triple-negative breast tumor cells Wnt pathway activity in breast cancer sub-types and stem-like cells The changing role of pathology in breast cancer diagnosis and treatment.

P2860

Q28075791-5CE408B5-EFD3-43BF-A536-550654E427D3 Q28252569-A7AC372A-6282-4A84-8546-61FA927DE827 Q28289776-63EDDBB3-95BB-4AFA-A192-C12FC16C1567 Q30993978-81DEAD1F-7606-4890-8B66-29396727488E Q31011613-9C7CC290-A180-4F70-AF5C-B338CEFEBB3D Q31142505-657416A7-3814-4141-9F28-C7D2FDABEBA7 Q33370712-BEFD3B27-266A-42CE-B9EE-BCD06D08828B Q33396559-90B60BA8-A4C7-477A-A227-8977ABC36738 Q33418745-D9B6151D-E8DB-4D92-8E34-4D09BD18D31D Q33511962-2AC4ECB0-D980-464E-A9F8-2A4E1D68FC65 Q33573884-E45D297C-31DE-42AC-8480-06D8D1A02DFE Q33588196-52525BC4-3DD7-4335-8748-B1DA0642029B Q33660965-7EDF1461-093B-4494-A61C-677E258F734B Q33688907-431BBD1D-14DD-48EC-A603-7E5C0BB329B0 Q33701691-D1811724-2243-489F-81AE-6308BEDA8B36 Q33730375-748DAE01-AE0D-4F00-A25C-A622DD67F5E9 Q33794872-713240D8-38B7-49D5-9F5E-4AC408C5ECC7 Q33861620-8E7B92AF-4D65-416A-BD0B-81F39B706E30 Q33863531-D37C46C6-6133-48E7-8758-B341F651A035 Q33864102-D06D52CC-E8E7-4B58-8505-A9F42C18742B Q33875853-504956A4-2EBF-4CAD-9193-7C03FF35D454 Q33998432-50686BB8-5727-4807-8EC6-E2B13F07E471 Q34106175-779C7688-76D0-4FF1-92F7-AA6AC3AD2B5D Q34119756-5F00E7D9-306F-4789-829A-C73AEE935A86 Q34162501-25F9B324-32CD-4811-8B1C-1773BBB074D0 Q34167298-9798340F-64BD-4432-B774-0A30D4FB2BEB Q34268261-F90EE5FA-226F-445B-880B-FE0E5FCBFFBA Q34334159-977E63A9-7CEC-470E-B87E-6ADA191546E7 Q34378272-208F5DA7-0600-47CF-BB68-65FA48305AED Q34379330-6583FB10-0DBD-472C-ACCA-EB8693776D84 Q34382914-8CBD931D-8C0A-4D89-8D73-9C03200660B9 Q34474679-E935F97A-1834-4192-9EE9-AFFEE29BF692 Q34477879-338A1298-F762-4A8E-9193-EE0D55A96131 Q34562257-63759B2C-116D-4A50-9EC7-AB08D1CBB6E3 Q34577709-F15679DD-F5C9-4BF5-8AC0-6D51375B81B4 Q34613059-3F7B4A77-3E56-4936-8735-FEE54A449299 Q34639174-C75CA45D-9B33-4F79-9263-B6353F6BCB5A Q34647893-B6D43B86-A78A-41AC-81CB-F59B79F784FF Q34826223-E0B07A8C-FB49-4114-8248-658787C66903 Q35082260-CB06D79D-5DDB-40CC-88EF-B2E31956F29F

P2860

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients.

http://www.wikidata.org/entity/Q35605761

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Intrinsic molecular signature ...... -based cohort of 412 patients.

@ast

Intrinsic molecular signature ...... -based cohort of 412 patients.

@en

type

label

Intrinsic molecular signature ...... -based cohort of 412 patients.

@ast

Intrinsic molecular signature ...... -based cohort of 412 patients.

@en

prefLabel

Intrinsic molecular signature ...... -based cohort of 412 patients.

@ast

Intrinsic molecular signature ...... -based cohort of 412 patients.

@en

P1433

Q35605761-16A62E3A-34F6-46A1-A09C-A73B027C579E

P1476

Q35605761-83EF416A-DD77-41CF-9E5E-36C7FF2ACDFD

P2093

Q35605761-0CE765A4-8F29-46E6-9CC7-C0E08C8BB11B

Q35605761-432DF7EC-74A8-4ABD-AAEC-E37ABC611A1C

Q35605761-6C3C9763-D1F4-4C25-B49B-66E0D7B7AB36

Q35605761-B370C899-0166-4596-BC02-22C57E1B382B

Q35605761-B4C0D936-64B4-4F28-944B-0A92E7195690

Q35605761-C12A5DC3-F7CE-4689-BCBA-0C5021D2CC53

Q35605761-C6149E5D-D366-48CB-BB7F-B3F1D944A3DB

Q35605761-E5538878-86E0-41F4-8C1F-CBF216C1C368

P2860

Q35605761-01A0DB70-9F6D-4525-BDD9-509CF8524A82

Q35605761-1C0D9760-CEEF-4050-8E90-2EBE8E6BB672

Q35605761-41F549C6-70A2-49D7-A17B-6D3FB683765B

Q35605761-473BEB8D-CEAB-40CE-B7F0-E68CEAB53307

Q35605761-483F9383-9AB6-4EE1-ABC0-9E6F0F196FAD

Q35605761-4CB29937-C172-49F3-9A27-C24D9034E3BC

Q35605761-4D05B110-F700-4CC1-B413-286671A6B68E

Q35605761-61D02B47-2798-4CAC-A93B-DB9B5C06F43B

Q35605761-78A6701A-6E68-4CB3-8A81-E2AD1BF9A5CD

Q35605761-90EC8A04-F28E-44C7-BE45-0652CDD08759

P2888

Q35605761-018F61A2-35F6-4898-BA44-04FDEBEDF494

P304

Q35605761-8F6CE874-D4AB-419C-9B59-96A2F224FCF6

P31

Q35605761-1F674002-CDA4-4B87-9DD9-55D55010BC29

P356

Q35605761-BC6002C3-A124-4A4B-BB0C-A90116342B4E

P433

Q35605761-67096F74-97AF-4339-ACA6-3659CF15CE46

P478

Q35605761-311DDC05-442E-4283-9998-4279F51459B4

P50

Q35605761-4E5B1AD3-DE9E-4B08-A503-1A890F6A1960

Q35605761-AA5A3CDD-4F53-404D-9126-33480D22C1D9

Q35605761-BCB60BDE-F852-4AF8-BB74-E461A7D100CE

Q35605761-D25C8310-4BDA-47FF-A440-15A0DA53C42E

P577

Q35605761-05C7B446-FCE7-48F3-8811-2E9F39B5D078

P5875

Q35605761-500A4A97-714C-4713-961A-A50415CB075C

P6179

Q35605761-15BD9857-1FE3-4D97-A33B-15397BFACFF0

P698

Q35605761-2DBE2290-C7BA-4ED1-852D-C4FE42574A2F

P932

Q35605761-2DC7CDBF-4C2A-4798-A266-75CFB005380B

P356

P1433

Breast Cancer Research

P1476

Intrinsic molecular signature ...... -based cohort of 412 patients.

@en

P2093

Edison T Liu

http://www.w3.org/2001/XMLSchema#string

Gert Auer

http://www.w3.org/2001/XMLSchema#string

Johanna Smeds

http://www.w3.org/2001/XMLSchema#string

Jonas Bergh

http://www.w3.org/2001/XMLSchema#string

Judith Bjöhle

http://www.w3.org/2001/XMLSchema#string

Sigrid Klaar

http://www.w3.org/2001/XMLSchema#string

Ulrike Kronenwett

http://www.w3.org/2001/XMLSchema#string

Yudi Pawitan

http://www.w3.org/2001/XMLSchema#string

P2860

Bioconductor: open software development for computational biology and bioinformatics

Cluster analysis and display of genome-wide expression patterns

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

Correlation test to assess low-level processing of high-density oligonucleotide microarray data

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Molecular portraits of human breast tumours

Repeated observation of breast tumor subtypes in independent gene expression data sets

Role of HER2/neu in tumor progression and therapy

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

P2888

P304

R34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR1517

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Alexander Ploner

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6938363

http://www.w3.org/2001/XMLSchema#string

P6179

1004340956

http://www.w3.org/2001/XMLSchema#string

P698

16846532

http://www.w3.org/2001/XMLSchema#string

P932

1779468

http://www.w3.org/2001/XMLSchema#string